Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-23T03:05:40.587Z Has data issue: false hasContentIssue false
  • English
  • Français

X-ray powder diffraction data of lapatinib ditosylate monohydrate

Published online by Cambridge University Press:  29 February 2012

Peter Varlashkin
Peter Varlashkin*
Affiliation:
GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, North Carolina 27707, USA
*
a)Electronic mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

The room temperature powder pattern of lapatinib ditosylate monohydrate (active ingredient in Tykerb used to treat refractory breast cancer) was indexed and the cell from the single crystal X-ray diffraction structure was refined using the experimental capillary data. Unit-cell parameters for the orthorhombic compound with space group Pbca refined from powder diffraction data are a=9.6850±0.0009 Å, b=29.364±0.003 Å, and c=30.733±0.003 Å, α=β=γ=90°, z=8, V=8740.1 Å3. Values of 2θ, d, I, and Miller indices are reported.

Keywords

lapatiniblapatinib ditosylate monohydrateTykerbpowder diffraction datadrugbreast cancer
Type
New Diffraction Data
Information
Powder Diffraction , Volume 24 , Issue 3 , September 2009 , pp. 250 - 253
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Boultif, A. (2005). “History of the dichotomy method for powder pattern indexing,” Powder Diffr. PODIE2 20, 284–287. 10.1154/1.2135307CrossRefGoogle Scholar
Boultif, A. and Louer, D. (2004). “Powder pattern indexing with the dichotomy method,” J. Appl. Crystallogr. JACGAR 37, 724–731. 10.1107/S0021889804014876CrossRefGoogle Scholar
Copley, R. “Single crystal X-ray structure” (private communication).Google Scholar
de Wolff, P. M. (1968). “A simplified criterion for the reliability of a powder pattern indexing,” J. Appl. Crystallogr. JACGAR 1, 108–113. 10.1107/S002188986800508XCrossRefGoogle Scholar
Johnston, S. R. D. and Leary, A. (2006). “Lapatinib: A novel EGFR/HER2 tyrosine kinase inhibitor for cancer,” Drugs Today (Barc) 42, 441–453. 10.1358/dot.2006.42.7.985637 CrossRefGoogle ScholarPubMed
Smith, G. S. and Snyder, R. L. (1979). “F(N): A criterion for rating powder diffraction patterns and evaluating the reliability of powder pattern indexing,” J. Appl. Crystallogr. JACGAR 12, 60–65. 10.1107/S002188987901178XCrossRefGoogle Scholar